Thursday

Severe Heartburn Means Cancer

Heartburn can be both extremely both painful and fatiguing. Generally, people suffer from some degree of heartburn. Medical data indicates that most people get occasional heartburn at some time in their life. However many of these heartburn episodes go away by themselves or with the help of a minimum of medication. Severe heartburn is a sign of a more advanced illness known to medical personnel as gastroesophageal reflux disease (GERD). Here, conventional medicine is often weak in providing any positive benefit for severe Heartburn cases.

What is the real, underlying problem?

The weakening or the instability of the muscle separating the esophagus from the stomach means that stomach juices including acid reflux back into the esophagus. Ulceration of the esophagus is then the result because of the acid corrosion caused by the acidic stomach matter. The root of the problem is therefore typically the sphincter or one-way muscular valve that should block off the stomach from the esophagus. In severe cases, there may even be a pre-cancer condition known to doctors as Barrett's esophagus, and which necessitates immediate medical attention.

Other factors of Heartburn
People with asthma can make the situation even worse. This is because if the backward reflux of acid contents reaches the upper part of the esophagus, then the result may be fits of wheezing, hoarseness and drive coughing.

===>>> News: The Connection Between Asthma and Heartburn GERD

Which kind of people are more at risk of contracting heartburn?
There are several medical conditions that will bump up the risk of serious heartburn. Risk factors include hernias and diabetes as well as incorrect eating, such as too much fast food. Diseases of the auto immune system such as Raynaud Phenomenon, sceloderma and the CREST syndrome can all negatively impact this condition.

Right Heartburn Remedy
Because they do not take into consideration the long term causes, and may even have serious side effects when they are taken, modern medicines may even worsen the situation. And as most medications prescribed by physicians target only the symptoms of heartburn, they only really have a role to play in short term relief.

Heartburn sufferers are advised to limit or avoid intake of food that is fatty, high in caffeine, high in alcohol content, in chocolate, mint or sherbet, as well as eating less of the acid-type foods such as tomatoes, oranges, spinach, cauliflower, broccoli, Brussels sprouts and cabbage. Recent investigations have suggested that a correct diet, a healthy lifestyle and a holistic program which may include herbs and vitamins supplements are what is required to permanently cure severe GERD-related heartburn.

Jeff Martin is a medical researcher, certified nutritionist, health consultant and author of the #1 best-selling e-book, "Heartburn No More- Open The Door To an Acid Reflux Free Life". Jeff has written dozens of holistic health articles and has been featured in ezines and print magazines, as well as on hundreds of websites worldwide.

To Learn More About Jeff Martin´s Unique 5-Step Holistic Acid Reflux Cure System Visit: Heartburn and Acid Reflux


Tuesday

True Story About A Patient Overcoming GERD problem

Many people like Beth (which you can watch the video below) thought that their heartburn problem was a simple case and did not really bother about it.

When the symptoms got worse, they started to find something is serious about it.

Click this video to learn more about it: True Life Story: GERD

Thursday

News: Acid Reflux Pills Related to Increased Fracture Risk

(NewsInferno.com - 12 Aug 2008) - We have been reporting on drugs such as Prilosec and Nexium—part of a class of drugs called Proton Pump Inhibitors, or PPIs—that the US Food and Drug Administration (FDA) investigated for a suspected link between cardiac trouble and PPIs.  Also, because such drugs may be overly effective at stopping stomach acid production, they have been know to raise pneumonia, bone loss, and fracture risk; this, by over 40 percent in patients on long-term use.

Now, a new Canadian study of PPIs such as Aciphex, Nexium, Prevacid, Prilosec, and Protonix and osteoporosis-related fractures has revealed a link between long-term use of PPis and increased risk for such fractures of the hip, wrist, or spine.  The link appeared in patients taking PPIs after about seven years.  PPI drug makers claim they haven’t seen increased osteoporosis-related fracture risk in people using their products.

The study included about 63,000 adults aged 50 and older in Manitoba, Canada, and also included about 15,300 patients who sustained an osteoporosis-related fracture of the hip, spine, or wrist from 1996 to 2004.  The researchers, including University of Manitoba’s Laura Targownik, MD, MSHS, also reviewed participants’ prescription records and found that those who received an osteoporosis-related fracture were nearly twice as likely to have taken a PPI for at least seven years; those on PPIs for six or less were not linked to fracture risk.  Those with hip fractures were 62% more likely to have used a PPI for at least five years.

It remains unclear how PPIs might increase fracture risk, but some experts believe it may be related to their stomach acid inhibiting qualities.  Targownik’s team speculates that PPIs speed up bone mineral loss; however, the study doesn’t prove this.  Also, the researchers considered a variety of other factors, including participants’ other prescriptions, medical history, and income.

Meanwhile, long-term PPI use and fracture risk have been linked in previous research and that association “is certainly a strong basis for encouraging further investigation,” write the editorialists, who included J. Brent Richards, MD, of Canada’s McGill University.  “Certainly, at one extreme, such as in patients with bleeding ulcers, the beneficial effects may far outweigh the risks associated with fractures,” the editorial states. “At the other extreme, liberal prescription of proton pump inhibitors for nebulous disorders for extended periods of time is likely worth revisiting.”

Targownik’s study doesn’t specify which PPIs the patients took.  AstraZeneca, maker of Nexium responded, “AstraZeneca does not agree with the conclusion of the CMAJ study,” said spokeswoman Corey Windett   Judee Shuler, senior director of corporate communications for Eisai Inc., maker of Aciphex, said the results “warrant further study, as these fractures are important medical issues that can occur for a variety of reasons.

According to an editorial published along with the study and that appeared in the Canadian Medical Association’s journal, CMAJ , additional research is needed.  Until then, they suggest patients and their doctors reevaluate the risks and benefits of long-term PPI use.